BioCentury
ARTICLE | Financial News

Frequency raises $42M series B

January 11, 2019 5:31 PM UTC

Regenerative medicine company Frequency Therapeutics Inc. (Woburn, Mass.) raised $42 million on Jan. 7 in a series B round led by Taiwania Capital Management. Also participating were new investors Yonjin Capital and DF Investments and existing investors Polaris Founders Capital, Alexandria Venture Investments, CoBro Ventures, Korea Investment Partners and Emigrant Capital. Frequency completed a series A round in April 2017 bringing the total raised to date to $87 million (see "Frequency Therapeutics Completes Venture Financing")...

BCIQ Company Profiles

Frequency Therapeutics Inc.